Related Experiment Videos
Oral misoprostol administration for labor induction.
Andrew Weeks1, Zarko Alfirevic
1School of Reproductive and Developmental Medicine, University of Liverpool, Liverpool Women's Hospital, Liverpool, UK. aweeks@liv.ac.uk
Clinical Obstetrics and Gynecology
|August 4, 2006
Summary
Oral misoprostol is an effective labor induction agent, potentially reducing vaginal exams and infection risks. A maximum dose of 50 mcg every 4 hours is recommended for safety.
Area of Science:
- Obstetrics and Gynecology
- Pharmacology
Background:
- Induction of labor commonly requires repeated vaginal examinations, increasing patient discomfort and infection risk.
- Oral agents for labor induction offer a potentially more acceptable and safer alternative.
Purpose of the Study:
- To systematically review the efficacy and safety of oral misoprostol compared to other labor induction agents.
- To evaluate the benefits of oral misoprostol in terms of vaginal delivery rates, patient acceptability, and infection risk reduction.
Main Methods:
- A systematic review of 41 randomized controlled trials was performed.
- Studies compared oral misoprostol with various other labor induction methods, including dinoprostone and vaginal misoprostol.
Main Results:
- Oral misoprostol is effective in achieving vaginal delivery and may offer advantages over dinoprostone.
- While slower than vaginal misoprostol, oral administration is associated with lower rates of hyperstimulation at comparable doses.
- The use of oral misoprostol may decrease the need for frequent vaginal examinations, potentially lowering infection rates.
Conclusions:
- Oral misoprostol is a viable and effective option for labor induction.
- A recommended oral regimen involves a maximum of 50 mcg every 4 hours, prioritizing safety over speed.
- Further research may explore optimizing oral misoprostol regimens for improved labor induction outcomes.